iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage

    NEXT STORY
    CymaBay Therapeutics Announces Departure of Chief Medical Officer
    PREV STORY
    SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Alberta’s Top Business Leaders Announced for 2018 CEO Rescue in the Rockies for STARS

    Prominent Alberta-based CEOs will be airlifted into the wilderness for annual fundraiserCALGARY, Alberta, May ...

    author_avatar
    NASDAQ Market News

    Transparency notification pursuant to Article 14 of the Law of May 2, 2007

    REGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May ...

    author_avatar
    NASDAQ Market News

    Editas Medicine Announces First Quarter 2018 Results and Update

    Expanded Celgene collaboration to drive lead oncology program in solid tumors Strengthened Board of ...

    author_avatar
    NASDAQ Market News